2020 Chronic Lymphocytic Leukaemia (CLL) TP53 mutation analysis (pilot)

Scheme description
DNA analysis of chronic lymphocytic leukaemia samples for TP53 mutation analysis (pilot)
Disorders/Gene target(s)
Chronic Lymphocytic Leukaemia (CLL) TP53
Clinical cases
Three
Testing/analysis
TP53 variant detection
Sample type
DNA in TE buffer
Techniques
Any
Assessment
Eligibility
Any ERIC certified laboratory for TP53 testing
Languages
English
ISO17043 Accredited EQA
No
EQA timeline
Sample dispatchTo be confirmed
Testing period5 weeks
Assessment resultsTo be confirmed
Final Summary reportNot applicable
Other information
In collaboration with UK NEQAS LI. Submissions will be assessed against ERIC recommendations.
Fee
£100.00
GenQA code
2020CLLTP53
« Return to EQA scheme list
Go to top